Hyde Park Capital Announces $20 Million Unitranche Credit Facility For American Clinical Solutions

Hyde Park Capital Announces $20 Million Unitranche Credit Facility For American Clinical Solutions

Tampa, Florida – June 22, 2015 – Hyde Park Capital Advisors, LLC (“Hyde Park Capital”) is pleased to announce the closing of a $20 million unitranche credit facility for American Clinical Solutions LLC (“ACS”). The credit facility was led by Credit Suisse Asset Management’s Credit Suisse Park View BDC, Inc., and Capitala Finance Corp. (“Capitala Group”) also participated. ACS is a leading provider of urine and oral fluid drug confirmation testing services. Hyde Park Capital sourced the capital and served as the exclusive investment banker and financial advisor to ACS for this unsponsored leveraged dividend recap transaction.

Roger Brown, President of ACS, said, “We appreciate the experience, professionalism and resolve of Hyde Park Capital in concluding our financing transaction with Credit Suisse and Capitala Group. We operate in a rapidly changing healthcare environment and this relationship bridged by Hyde Park Capital positions ACS to focus on our continued growth strategy, future opportunities and diversification of our business model for many years.”

John McDonald, Senior Managing Director at Hyde Park Capital, stated, “We thank ACS for their confidence in our team at Hyde Park Capital and for the opportunity to be a part of this notable transaction. We look forward to watching the company continue to flourish in the future.”

About American Clinical Solutions, LLC

American Clinical Solutions LLC is a leading provider of urine and oral fluid drug confirmation testing services. ACS has developed a proprietary testing method with enhanced detection ability and improved accuracy. In addition to detecting improper use of prescribed and illicit drugs, the Company’s testing method helps healthcare providers monitor the efficacy of prescription regimens and alter the dosing scheme in response to changes in a patient’s health status, behavior or other variables, helping patients achieve better outcomes while providing a higher level of safety. More information about ACS is available at www.acslabtest.com.

About Credit Suisse Asset Management

In its Asset Management business, Credit Suisse offers products across a broad spectrum of investment classes, including hedge funds, credit, index, real estate, commodities and private equity products, as well as multi-asset class solutions, which include equities and fixed income products. Credit Suisse’s Asset Management business manages portfolios, mutual funds, business development companies and other investment vehicles for a broad spectrum of clients ranging from governments, institutions and corporations to private individuals. With offices focused on asset management in 19 countries, Credit Suisse’s Asset Management business is operated as a globally integrated network to deliver the bank’s best investment ideas and capabilities to clients around the world.

All businesses of Credit Suisse are subject to distinct regulatory requirements; certain products and services may not be available in all jurisdictions or to all client types. More information about Credit Suisse may be obtained from its website at www.creditsuisse.com.

About Capitala Group

Capitala Group is a leading provider of capital to lower and traditional middle-market companies, through its family of credit focused funds. Since 1998, Capitala Group’s managed funds have participated in over 100 transactions, representing approximately $700 million of investments in a variety of industries throughout North America. Capitala Group manages both public capital (Capitala Finance Corp (Nasdaq:CPTA)) and private capital (including but not limited to the CapitalSouth Growth Fund) for its investors and seeks to partner with strong management teams to create value and serve as long term partners. To learn more about Capitala Group, please visit www.CapitalaGroup.com

About Hyde Park Capital

Hyde Park Capital is an institutionally focused investment banking firm specializing in mergers and acquisitions and private placements of debt and equity and serving the corporate finance needs of middle market public and private companies. Our principals have extensive investment banking experience executing merger & acquisition engagements, including purchase and sale of company assignments, recapitalizations, financial advisory, fairness opinions and raising growth capital and acquisition financing for companies, including equity, mezzanine and senior debt.  As one of the most active investment banking firms in the Southeast, our professionals have advised on more than 300 corporate investment banking transactions totaling more than $10 billion in transaction value. We are headquartered in Tampa, Florida and are a member of FINRA and SIPC. For additional information about Hyde Park Capital, visit www.hydeparkcapital.com or call (813) 383-0202.

Client Testimonials

"Hyde Park’s team guided us through the process, providing us with a number of high quality counter-parties, and supported us through the transaction structuring, negotiation and due diligence. We are very pleased with the outcome and excited for the future of DTS.”
Allen Ibaugh, Co-Founder and CEO of Data Transfer Solutions
“We enjoyed working with Hyde Park Capital and appreciated their M&A expertise in the technology services sector and their help on this important transaction.”
Chris Toepke, CEO of Trifecta
“We very much appreciated the assistance of Hyde Park Capital on this strategic acquisition for ITE. Their M&A experience was quite helpful to our team and the overall process and assured the deal was well executed and we got it closed on schedule.”
Scott Dols, CEO of Industrial Truck & Equipment, LLC
SEE ALL TESTIMONIALS